The elevated ZEB1 expression demonstrated a statistically significant association with a reduced risk of BCR for our cohort of intermediate-risk PCa, as determined by Kaplan–Meier analysis, (log-rank test p = 0.04) (Figure 2E). The gene discussed is ZEB1; the disease is posterior cortical atrophy.